<code id='277C97F5CA'></code><style id='277C97F5CA'></style>
    • <acronym id='277C97F5CA'></acronym>
      <center id='277C97F5CA'><center id='277C97F5CA'><tfoot id='277C97F5CA'></tfoot></center><abbr id='277C97F5CA'><dir id='277C97F5CA'><tfoot id='277C97F5CA'></tfoot><noframes id='277C97F5CA'>

    • <optgroup id='277C97F5CA'><strike id='277C97F5CA'><sup id='277C97F5CA'></sup></strike><code id='277C97F5CA'></code></optgroup>
        1. <b id='277C97F5CA'><label id='277C97F5CA'><select id='277C97F5CA'><dt id='277C97F5CA'><span id='277C97F5CA'></span></dt></select></label></b><u id='277C97F5CA'></u>
          <i id='277C97F5CA'><strike id='277C97F5CA'><tt id='277C97F5CA'><pre id='277C97F5CA'></pre></tt></strike></i>

          fashion

          fashion

          author:explore    Page View:55

          The Senate has set its eyes on regulating insurance plans for some of the most vulnerable patients in the U.S. — the 12.5 million people eligible for both Medicare and Medicaid.

          “They’re a complex group of people with a lot of chronic conditions — mental illness, frailty, disability,” said Jose Figueroa, an internal medicine physician and health policy expert at Brigham and Women’s Hospital. Over a third of these dual-eligible beneficiaries have less than a high school education, and about 90% make less than $20,000 per year.

          advertisement

          Just around 15% of beneficiaries are eligible for both Medicare and Medicaid, but they account for a third of these programs’ spending — around $440 billion — and still don’t receive better health care, Sen. Bill Cassidy (R-La.) pointed out in a JAMA viewpoint published earlier this month. “The root cause of worse outcomes despite spending more money is a lack of coordination of care,” Cassidy wrote.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          What to know about Virgin Galactic's 1st mission taking paying customers to space
          What to know about Virgin Galactic's 1st mission taking paying customers to space

          1:42TheVirginGalacticSpaceShipTwospaceplaneUnityreturnstoearthaboveSpaceportAmerica,nearTruthandCons

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          A biotech analyst on neuroscience, placebo effect, not over

          PaulMatteis(right),in2017withthen-colleaguesSeamusFernandez(farleft)GeoffreyPorges.AlexHogan/STATNEW